Highlighting the event is the immersive simulation, “Seeing Beyond the Ordinary and Repairing Damages,” led by world-renowned ...

Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients with lower vision, according to a speaker here. During a presentation at ...

Luo, Y.N., Lu, J., Liang, G.H. and Ma, W.H. (2025) Long-Term Opacity of Intraocular Lens after Cataract Surgery in 1 Case. Journal of Biosciences and Medicines, 13, 206-214. doi: ...

New duodenal ablation techniques are under investigation, such as submucosal laser ablation and a technique using ... that 69% of patients were able to make a step back on the diabetes treatment ...

PEOPLE TAKING GLP-1S have a reduced risk of heart attacks, strokes, and death from cardiovascular disease, according to a ...

Due to hormonal imbalance, women's periods become irregular in PCOD, and they start gaining weight and hair fall. While hair ...

Fluorescein Angiography Market Research 2024-2033: Strategic Collaborations Expanding Access To Advanced Eye Care Technologies Spurring Growth ...

Belarus’ NAS has selected top ten significant research and developments for the countryEvery year, Belarusian scientists diligently work ...

The medical device industry is at the forefront of innovation, transforming healthcare delivery through groundbreaking technologies. At the center of this progress are life science innovations, which ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has accepted ...

An FDA approval later this year for Arrowhead’s plozasiran in FCS would put it in direct competition with Ionis’ Tryngolza.

Dermal filler-induced alopecia is a rare yet significant complication arising from aesthetic procedures, primarily linked to ...